1. Home
  2. EFSC vs LQDA Comparison

EFSC vs LQDA Comparison

Compare EFSC & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EFSC
  • LQDA
  • Stock Information
  • Founded
  • EFSC 1988
  • LQDA 2004
  • Country
  • EFSC United States
  • LQDA United States
  • Employees
  • EFSC N/A
  • LQDA N/A
  • Industry
  • EFSC Major Banks
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • EFSC Finance
  • LQDA Health Care
  • Exchange
  • EFSC Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • EFSC 2.2B
  • LQDA 1.9B
  • IPO Year
  • EFSC 1999
  • LQDA 2018
  • Fundamental
  • Price
  • EFSC $57.05
  • LQDA $24.08
  • Analyst Decision
  • EFSC Strong Buy
  • LQDA Strong Buy
  • Analyst Count
  • EFSC 3
  • LQDA 9
  • Target Price
  • EFSC $64.33
  • LQDA $32.67
  • AVG Volume (30 Days)
  • EFSC 157.2K
  • LQDA 2.9M
  • Earning Date
  • EFSC 10-27-2025
  • LQDA 11-12-2025
  • Dividend Yield
  • EFSC 2.15%
  • LQDA N/A
  • EPS Growth
  • EFSC 15.35
  • LQDA N/A
  • EPS
  • EFSC 5.26
  • LQDA N/A
  • Revenue
  • EFSC $637,581,000.00
  • LQDA $19,322,000.00
  • Revenue This Year
  • EFSC $18.12
  • LQDA $405.58
  • Revenue Next Year
  • EFSC $4.60
  • LQDA $373.93
  • P/E Ratio
  • EFSC $10.95
  • LQDA N/A
  • Revenue Growth
  • EFSC 9.46
  • LQDA 30.20
  • 52 Week Low
  • EFSC $45.22
  • LQDA $9.71
  • 52 Week High
  • EFSC $63.13
  • LQDA $29.94
  • Technical
  • Relative Strength Index (RSI)
  • EFSC 43.64
  • LQDA 52.50
  • Support Level
  • EFSC $57.40
  • LQDA $21.35
  • Resistance Level
  • EFSC $58.81
  • LQDA $23.33
  • Average True Range (ATR)
  • EFSC 1.21
  • LQDA 1.18
  • MACD
  • EFSC -0.28
  • LQDA 0.05
  • Stochastic Oscillator
  • EFSC 17.87
  • LQDA 83.30

About EFSC Enterprise Financial Services Corporation

Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: